|
QLT reports $10.5-million loss
Vancouver Sun, Canada - Apr 26, 2008 In its first quarter, QLT sold $36.5 million US worth of the macular-degeneration blindness treatment, Visudyne, down 40 per cent from the same quarter a … QLT announces first quarter results for 2008 Canada NewsWire (press release) QLT suffers Q1 loss of US$10.5M as Visudyne eye drug sales fade 40 … CFTKTV QLT loss no surprise to investors, analysts Vancouver Sun all 67 news articles |
Macular Degeneration Subscriber
